![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1423-0208|27|4|222-229
ISSN: 0251-5350
Source: Neuroepidemiology, Vol.27, Iss.4, 2006-12, pp. : 222-229
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Vitamin Intervention for Stroke Prevention (VISP) Trial: Rationale and Design
Neuroepidemiology, Vol. 20, Iss. 1, 2001-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Risk and Benefit of Statins in Stroke Secondary Prevention
Current Vascular Pharmacology, Vol. 11, Iss. 6, 2013-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Risk Factors and Stroke Prevention
Cerebrovascular Diseases, Vol. 10, Iss. 3, 2000-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clopidogrel in Secondary Ischemic Stroke Prevention
Recent Patents on Cardiovascular Drug Discovery, Vol. 3, Iss. 2, 2008-06 ,pp. :